195 related articles for article (PubMed ID: 20052552)
1. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
3. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
4. Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy.
Provatopoulou X; Kalogera E; Sagkriotis A; Zagouri F; Nonni A; Zografos GC; Gounaris A
Anticancer Res; 2012 Mar; 32(3):1021-6. PubMed ID: 22399626
[TBL] [Abstract][Full Text] [Related]
5. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
6. Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro.
Yie SM; Li LH; Li GM; Xiao R; Librach CL
Hum Reprod; 2006 Jan; 21(1):46-51. PubMed ID: 16210391
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
Calaf GM
Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
9. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
10. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.
Sayed D; Badr G; Maximous D; Mikhail NN; Abu-Tarboush F; Alhazza IM
Tissue Antigens; 2010 Jan; 75(1):40-7. PubMed ID: 20196818
[TBL] [Abstract][Full Text] [Related]
11. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
12. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
[TBL] [Abstract][Full Text] [Related]
13. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
Dehmel A; Becker M; Lemm M; Fichtner I
Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
19. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
20. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
